On February 19, 2015, the United States Food and Drug Administration (FDA) issued a safety communication to healthcare professionals regarding the design of certain reusable Duodenoscopes that may impede effective cleaning. AMDR member companies in the U.S. do not reprocess the Endoscopic Retrograde Cholangiopancreatography (ERCP) devices that are the subject of this notice, nor do AMDR members generally reprocess reusable devices or devices that are reprocessed in healthcare facilities. AMDR represents commercial, third-party reprocessors of “single-use” devices. Our members operate independent facilities that are subject to all of FDA medical device manufacturer requirements. All U.S. members of AMDR are in substantial compliance with FDA’s requirements.